ClinicalTrialsFinder

Refractory Triple-Negative Breast Carcinoma Clinical Trials in Buffalo, New York

1 recruitingBuffalo, New York

Showing 1–1 of 1 trials

Recruiting
Phase 2

Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer

Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Metastatic Triple-Negative Breast Carcinoma+2 more
Emory University37 enrolled2 locationsNCT05741164